We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

216 hedge funds and large institutions have $1.25B invested in Dynavax Technologies in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 86 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $4.39M | Put options by funds: $1.59M

7.96% more ownership

Funds ownership: 92.2%100.16% (+8%)

2% more capital invested

Capital invested by funds: $1.23B → $1.25B (+$22M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

6% less funds holding

Funds holding: 230216 (-14)

24% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 86

31% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 39

Holders
216
Holders Change
-14
Holders Change %
-6.09%
% of All Funds
3.44%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
65
Reduced
86
Closed
39
Calls
$4.39M
Puts
$1.59M
Net Calls
+$2.81M
Net Calls Change
-$2.63M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$185M -$2.25M -210,409 -1%
Federated Hermes
2
Federated Hermes
Pennsylvania
$124M +$160K +15,000 +0.1%
State Street
3
State Street
Massachusetts
$87.7M -$11.2M -1,048,856 -10%
Vanguard Group
4
Vanguard Group
Pennsylvania
$82.9M +$1.13M +106,036 +1%
DTC
5
Deep Track Capital
Connecticut
$62.3M +$42.9M +4,022,049 +173%
CC
6
Chicago Capital
Illinois
$57.3M -$108K -10,088 -0.2%
Bank of America
7
Bank of America
North Carolina
$42.6M +$41.2M +3,864,170 +812%
BCLSI
8
Bain Capital Life Sciences Investors
Massachusetts
$38.4M
Fisher Asset Management
9
Fisher Asset Management
Washington
$38.1M -$2.1M -197,164 -5%
PHS
10
PFM Health Sciences
California
$37.3M
Goldman Sachs
11
Goldman Sachs
New York
$36.3M +$22.5M +2,107,157 +132%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$28.8M +$12.2M +1,140,347 +64%
Renaissance Technologies
13
Renaissance Technologies
New York
$26M +$11.1M +1,035,658 +64%
William Blair & Company
14
William Blair & Company
Illinois
$24.8M +$465K +43,550 +2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$22.7M +$1.03M +96,747 +4%
Morgan Stanley
16
Morgan Stanley
New York
$20.7M +$689K +64,592 +3%
EDRH
17
Edmond de Rothschild Holding
Switzerland
$19.7M
RSCM
18
Rock Springs Capital Management
Maryland
$17.8M
Northern Trust
19
Northern Trust
Illinois
$13.4M -$24.4K -2,283 -0.2%
Invesco
20
Invesco
Georgia
$13.3M +$453K +42,405 +3%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$11.1M -$431K -40,384 -3%
DCM
22
Driehaus Capital Management
Illinois
$10.9M -$548K -51,341 -4%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$10.2M -$617K -57,800 -5%
Charles Schwab
24
Charles Schwab
California
$9.23M +$35.5K +3,321 +0.4%
Macquarie Group
25
Macquarie Group
Australia
$7.46M

DVAX Hedge Fund Activity: Q1 2023 in Review

216 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2023, worth a combined $1.25B — up 1.8% from $1.23B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of DVAX and 27 opened new positions — a net loss of 12 holders — while 86 trimmed existing stakes and 65 added.

The largest buyer was Deep Track Capital, adding an estimated $42.9M. The largest seller was State Street, cutting an estimated $11.2M.

  • 216 institutional investors held Dynavax Technologies (DVAX) as of Q1 2023, down from 230 in Q4 2022.
  • Funds reported $1.25B of Dynavax Technologies stock for Q1 2023, up 1.8% quarter-over-quarter.
  • 27 funds opened new Dynavax Technologies positions in Q1 2023 and 39 closed out, a net change of -12 holders.
  • The largest Dynavax Technologies buyer in Q1 2023 was Deep Track Capital, an estimated $42.9M added.
  • The largest Dynavax Technologies seller in Q1 2023 was State Street, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2023.